TY - JOUR
T1 - Applications of deuterium in medicinal chemistry
AU - PIRALI, Tracey
AU - Serafini, Marta
AU - CARGNIN, Sarah
AU - Genazzani, Armando
N1 - Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019
Y1 - 2019
N2 - The use of deuteration in medicinal chemistry has exploded in the last years and the FDA has recently approved the first deuterium-labelled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of co-administered boosters and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.
AB - The use of deuteration in medicinal chemistry has exploded in the last years and the FDA has recently approved the first deuterium-labelled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of co-administered boosters and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.
UR - https://iris.uniupo.it/handle/11579/99823
U2 - 10.1021/acs.jmedchem.8b01808
DO - 10.1021/acs.jmedchem.8b01808
M3 - Article
SN - 0022-2623
VL - 62
SP - 5266
EP - 5297
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 11
ER -